Analyst Ratings for CME Group Inc. Cl A (CME)Updated: 2017-07-28
CME Group Inc. Cl A (NASDAQ:CME) was awarded an average rating of Overweight from investment analysts following the stock. CME had previously received a consensus rating of Overweight a month ago.
16 analysts issued ratings on the stock, where 9 gave CME a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 1 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
Several price targets were given for CME by the analysts covering the stock. The most optimistic analyst gave a price target of 140, implying a possible profit of 15.3 percent. The most pessimistic analyst gave a price target of 106, implying a possible loss of -12.7 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -1.23 percent. The average change in earnings estimates over the last 90 days is -3.23 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -0.51 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 2 analysts increased their quarterly estimates, which can be compared to the 5 analysts that decreased their estimates. During this time, 4 analysts made positive revisions in their estimates for this fiscal year's earnings, while 4 analysts made negative revisions to their fiscal year's estimates.
Analysts estimate earnings of CME to grow at a rate of 4.99 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of CME is 5.27.
In the trailing 52-weeks, CME hit 127.96 at the highest peak, while it's lowest trading point was 98.95. Today's price is 22.71 percent above the 52-week low, and 5.11 percent lower than its 52-week high. CME has a price/earnings ratio of 26.3. Investors typically compare the P/E ratio to a company's peers in the industry. The CME value stock report compares CME to some of its peers using value stock charts. The market cap of CME is $41.24 billion. CME's next earnings release will be on 0000-00-00, which is days away.